Crinetics Pharmaceuticals Inc CRNX

NAS: CRNX | ISIN: US22663K1079 12/11/2024

58,78 USD (-2,05%)

(-2,05%) 12/11/2024

Grafiek Crinetics Pharmaceuticals Inc

Grafiek Crinetics Pharmaceuticals Inc

1 dag1d -2,05%
1 week1w -0,64%
1 maand1m 10,70%
3 maanden3m 16,79%
6 maanden6m 22,64%
1 jaar1j 107,85%
5 jaar5j 206,47%

Crinetics Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

12 maart 2021 · Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs · Persbericht

4 februari 2021 · Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study · Persbericht

3 februari 2021 · Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study · Persbericht

6 januari 2021 · Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Crinetics Pharmaceuticals Inc

Gezondheidstechnologie

Website: www.crinetics.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: R. Scott Struthers

Werknemers: 194

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe